Iradimed Corp. (IRMD) Tops Q1 EPS by 2c

Iradimed Corp. (NASDAQ: IRMD) reported Q1 EPS of $0.14, $0.02 better than the analyst estimate of $0.12. Revenue for the quarter came in at $7 million versus the consensus estimate of $6.9 million.

For earnings history and earnings-related data on Iradimed Corp. (IRMD) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Nike names former Pfizer CFO David Denton as new finance chief
• Cerebras Q1 EPS miss sends shares down 9% after-hours